Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Researchers at New York University Abu Dhabi (NYUAD) have developed Spheromatrix, a simple and low-cost technology that ...

Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...

Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide not only reduce body weight in obesity but are also approved to treat other ...

Oct 28 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it was collaborating with Nvidia (NVDA.O), opens new tab to build a supercomputer to help with drug discovery and shorten ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Lisa Stiffler on Oct 10, 2025 at ...

ATLANTA, Ga. – The Drug Enforcement Administration (DEA) in Atlanta has a new tool in its fight against one of Mexico's most notorious cartels. The DEA Atlanta Field Division opened a new lab in May ...

In taking the unusual step of approving an old generic drug as a treatment for autism, the Food and Drug Administration stunned some experts by departing sharply from the agency’s typical standard for ...

Lucy Xiaolu Wang does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers scrambling to buy over-the-counter supplements with the same ingredients. By ...